12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Company News  |  Deals

Sequenta, iRepertoire deal

iRepertoire granted Sequenta exclusive rights to IP on methods of immune cell sequencing for all applications of minimal residual disease...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >